Identification of a New Type of Covalent PPARγ Agonist using a Ligand-Linking Strategy
- Anna Ohtera ,
- Yusaku Miyamae ,
- Kotaro Yoshida ,
- Kazuhiro Maejima ,
- Toru Akita ,
- Akira Kakizuka ,
- Kazuhiro Irie ,
- Seiji Masuda ,
- Taiho Kambe , and
- Masaya Nagao
Abstract
Peroxisome proliferator-activated receptor γ (PPARγ) is a ligand-activated transcription factor that plays an important role in adipogenesis and glucose metabolism. The ligand-binding pocket (LBP) of PPARγ has a large Y-shaped cavity with multiple subpockets where multiple ligands can simultaneously bind and cooperatively activate PPARγ. Focusing on this unique property of the PPARγ LBP, we describe a novel two-step cell-based strategy to develop PPARγ ligands. First, a combination of ligands that cooperatively activates PPARγ was identified using a luciferase reporter assay. Second, hybrid ligands were designed and synthesized. For proof of concept, we focused on covalent agonists, which activate PPARγ through a unique activation mechanism regulated by a covalent linkage with the Cys285 residue in the PPARγ LBP. Despite their biological significance and pharmacological potential, few covalent PPARγ agonists are known except for endogenous fatty acid metabolites. With our strategy, we determined that plant-derived cinnamic acid derivatives cooperatively activated PPARγ by combining with GW9662, an irreversible antagonist. GW9662 covalently reacts with the Cys285 residue. A docking study predicted that a cinnamic acid derivative can bind to the open cavity in GW9662-bound PPARγ LBP. On the basis of the putative binding mode, structures of both ligands were linked successfully to create a potent PPARγ agonist, which enhanced the transactivation potential of PPARγ at submicromolar levels through covalent modification of Cys285. Our approach could lead to the discovery of novel high-potency PPARγ agonists.
Cited By
This article is cited by 13 publications.
- Taku Tsukidate, Qiang Li, Howard C. Hang. Nuclear Receptor Chemical Reporter Enables Domain-Specific Analysis of Ligands in Mammalian Cells. ACS Chemical Biology 2020, 15 (9) , 2324-2330. https://doi.org/10.1021/acschembio.0c00432
- Richard Brust, Hua Lin, Jakob Fuhrmann, Alice Asteian, Theodore M. Kamenecka, and Douglas J. Kojetin . Modification of the Orthosteric PPARγ Covalent Antagonist Scaffold Yields an Improved Dual-Site Allosteric Inhibitor. ACS Chemical Biology 2017, 12 (4) , 969-978. https://doi.org/10.1021/acschembio.6b01015
- Åsmund Kaupang, Trond Vidar Hansen. The PPAR Ω Pocket: Renewed Opportunities for Drug Development. PPAR Research 2020, 2020 , 1-21. https://doi.org/10.1155/2020/9657380
- Yuanyuan Cheng, Dan Luo, Yingke Zhao, Jianhui Rong. N-Propargyl caffeate amide (PACA) prevents cardiac fibrosis in experimental myocardial infarction by promoting pro-resolving macrophage polarization. Aging 2020, 12 (6) , 5384-5398. https://doi.org/10.18632/aging.102959
- Jun Young Jang, Hyunsoo Kim, Hyun-Jung Kim, Se Won Suh, Seung Bum Park, Byung Woo Han. Structural basis for the inhibitory effects of a novel reversible covalent ligand on PPARγ phosphorylation. Scientific Reports 2019, 9 (1) https://doi.org/10.1038/s41598-019-47672-w
- Yuki Utsugi, Hirona Kobuchi, Yukio Kawamura, Ahmed Salahelden Aboelhamd Atito, Masaya Nagao, Hiroko Isoda, Yusaku Miyamae. Importance of the Proximity and Orientation of Ligand-Linkage to the Design of Cinnamate-GW9662 Hybrid Compounds as Covalent PPARγ Agonists. Molecules 2019, 24 (10) , 2019. https://doi.org/10.3390/molecules24102019
- Mari Morimoto, Mizuki Mitsukawa, Chisato Fujiwara, Yukio Kawamura, Seiji Masuda. Inhibition of mRNA processing activity from ginger-, clove- and cinnamon-extract, and by two ginger constituents, 6-gingerol and 6-shogaol. Bioscience, Biotechnology, and Biochemistry 2019, 83 (3) , 498-501. https://doi.org/10.1080/09168451.2018.1547107
- Agha Zeeshan Mirza, Ismail I. Althagafi, Hina Shamshad. Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications. European Journal of Medicinal Chemistry 2019, 166 , 502-513. https://doi.org/10.1016/j.ejmech.2019.01.067
- Masashi Kurata, Yuki Murata, Keiko Momma, Intisar Fouad Ali Mursi, Masakazu Takahashi, Yusaku Miyamae, Taiho Kambe, Masaya Nagao, Hiroshi Narita, Yasuyuki Shibuya, Seiji Masuda. The isoflavone fraction from soybean presents mRNA maturation inhibition activity. Bioscience, Biotechnology, and Biochemistry 2017, 81 (3) , 551-554. https://doi.org/10.1080/09168451.2016.1249451
- Michele Vasaturo, Lorenzo Fiengo, Nunziatina De Tommasi, Lina Sabatino, Pamela Ziccardi, Vittorio Colantuoni, Maurizio Bruno, Carmen Cerchia, Ettore Novellino, Angelo Lupo, Antonio Lavecchia, Fabrizio Dal Piaz. A compound-based proteomic approach discloses 15-ketoatractyligenin methyl ester as a new PPARγ partial agonist with anti-proliferative ability. Scientific Reports 2017, 7 (1) https://doi.org/10.1038/srep41273
- Colin M. Tice, Ya-Jun Zheng. Non-canonical modulators of nuclear receptors. Bioorganic & Medicinal Chemistry Letters 2016, 26 (17) , 4157-4164. https://doi.org/10.1016/j.bmcl.2016.07.067
- Yusaku Miyamae, Yukina Nishito, Naomi Nakai, Yoko Nagumo, Takeo Usui, Seiji Masuda, Taiho Kambe, Masaya Nagao. Tetrandrine induces lipid accumulation through blockade of autophagy in a hepatic stellate cell line. Biochemical and Biophysical Research Communications 2016, 477 (1) , 40-46. https://doi.org/10.1016/j.bbrc.2016.06.018
- Yusaku MIYAMAE, Masaya NAGAO. . Kagaku To Seibutsu 2016, 54 (11) , 791-793. https://doi.org/10.1271/kagakutoseibutsu.54.791